Cargando…
Clinical implications of drug-screening assay for recurrent metastatic hormone receptor-positive, human epidermal receptor 2-negative breast cancer using conditionally reprogrammed cells
Various new drugs have been developed for treating recurrent hormone receptor-positive (HR+)/human epidermal receptor 2-negative (HER2−) breast cancer. However, directly identifying effective drugs remains difficult. In this study, we elucidated the clinical relevance of cultured cells derived from...
Autores principales: | Mimoto, Rei, Yogosawa, Satomi, Saijo, Hiroki, Fushimi, Atsushi, Nogi, Hiroko, Asakura, Tadashi, Yoshida, Kiyotsugu, Takeyama, Hiroshi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6746954/ https://www.ncbi.nlm.nih.gov/pubmed/31527634 http://dx.doi.org/10.1038/s41598-019-49775-w |
Ejemplares similares
-
Dual‐specificity tyrosine‐regulated kinase 2 is a suppressor and potential prognostic marker for liver metastasis of colorectal cancer
por: Ito, Daisuke, et al.
Publicado: (2017) -
Tumor suppressive role for kinases phosphorylating p53 in DNA damage‐induced apoptosis
por: Yogosawa, Satomi, et al.
Publicado: (2018) -
Downregulation of dual‐specificity tyrosine‐regulated kinase 2 promotes tumor cell proliferation and invasion by enhancing cyclin‐dependent kinase 14 expression in breast cancer
por: Imawari, Yoshimi, et al.
Publicado: (2018) -
Roles of activin receptor-like kinase 7 signaling and its target, peroxisome proliferator-activated receptor γ, in lean and obese adipocytes
por: Yogosawa, Satomi, et al.
Publicado: (2013) -
Downregulation of CD24 suppresses bone metastasis of lung cancer
por: Okabe, Hinako, et al.
Publicado: (2017)